Table 3B.

Pre- and Postdrug Measurements of Peak Sagittal-Plane Joint Range of Motion of the Hip, Knee, and Ankle at Fastest Matched Speed

	SSRI			5HT antagonist
Fastest matched	Pre	Post	p value	Pre	Post	p value
More impaired limb
Ankle dorsiflexion	18±7	18±5	0.98	20±10	20±10	0.84
Ankle plantarflexion	−21±10	−16±13	0.07	−22±14	−23±14	0.70
Knee flexion	−60±13	−56±16	0.16	−62±19	−61±16	0.75
Knee extension	−6±16	−5±18	0.84	−8±15	−6±12	0.44
Hip flexion	37±14	35±11	0.75	38±11	42±12	0.29
Hip extension	−14±15	−11±9	0.38	−9±7	−6±8	0.48
Hip-knee ACC	0.88±0.04	0.88±0.04	0.61	0.86±0.07	0.86±0.08	0.36
Less impaired limb
Ankle dorsiflexion	16±6.2	18±7.8	0.16	18±6.2	17±10	0.57
Ankle plantarflexion	−12±11	−8.2±9.3	0.06	−14±14	−17±15	0.43
Knee flexion	−58±8.5	−62±10	0.09	−59±8.9	−60±6.6	0.51
Knee extension	−6.8±18	−11±19	0.07	−8.2±19	−6.9±16	0.39
Hip flexion	35±16	41±6.7	0.27	38±7.4	42.6±7.4	0.18
Hip extension	−15±16	−7.6±8.9	0.18	−11±12	−7.3±7.4	0.32
Hip-knee ACC	0.88±0.08	0.90±0.06	0.27	0.88±0.07	0.88±0.10	0.79

Negative values represent plantarflexion at the ankle, flexion at the knee, and extension at the hip. Values are presented in degrees (mean±standard deviation).

SSRI, selective serotonin reuptake inhibitor; 5HT, serotonergic; ACC, average coefficient of correlation.